The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.
October 25, 2018
Full of our informative publications, including our Patient Handbook and selections from the popular Understanding Series, the Info Pack will…
June 01, 2022
This publication discusses the use of Velcade (bortezomib)—a proteasome inhibitor—for the treatment of myeloma.
June 01, 2022
This booklet discusses dexamethasone, a synthetic steroid that is one of the most frequently used medications in the treatment of myeloma. It can be…
June 01, 2022
This publication discusses the use of Ninlaro (ixazomib)—a proteasome inhibitor—for the treatment of myeloma.
June 29, 2022
Carvykti™ (ciltacabtagene autoleucel, or “cilta-cel” for short) is a customized immunotherapy approved by the FDA for the treatment of adult…
We Thank Our Sponsors:
BMS, Janssen, Karyopharm Therapeutics, Legend Biotech, and Takeda Pharmaceuticals U.S.A., Inc.